Ultragenyx Pharmaceutical Inc. (RARE) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportAug 1, 2024

Stimato per Q2 24:$-1.57

Cambiamenti implicati per il Q1 24:-22.66%

Cambiamenti implicati per il Q2 23:-30.22%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q1 24	May 2, 2024	$-2.03 / $-1.72	$-0.31 / -18.02%
Q4 23	Feb 15, 2024	$-1.52 / $-1.65	$0.13 / 7.88%
Q3 23	Nov 2, 2023	$-2.23 / $-2.08	$-0.15 / -7.21%
Q2 23	Aug 3, 2023	$-2.25 / $-2.11	$-0.14 / -6.64%
Q1 23	May 4, 2023	$-2.33 / $-1.97	$-0.36 / -18.27%
Q4 22	Feb 16, 2023	$-2.16 / $-2.03	$-0.13 / -6.4%
Q3 22	Nov 2, 2022	$-2.43 / $-2.29	$-0.14 / -6.11%
Q2 22	Jul 28, 2022	$-2.26 / $-1.72	$-0.54 / -31.4%

Fornitori di Dati: Xignite Logo